As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.
Aging Brain is an Open Access journal that complements Neurobiology of Aging which, in its 40th anniversary in 2020, is the premier journal in the field of aging neuroscience. Aging Brain will publish papers that contribute to knowledge of the mechanisms underlying healthy (or adaptive) and pathological aging of the brain, as well as the iterative communication of signals between the brain, other organs and the external environment that promote or disrupt the mental health span. Papers that employ multiple levels of analysis, that integrate knowledge from established and emerging disciplines and technological developments, and which demonstrate translation into improved medical approaches, are particularly welcome.The journal accepts: Original research, Reviews, Short Communications, Registered Reports, Point of Interest and Letters to the Editor, provided they demonstrate originality, scientific rigor, observance of ethical standards and represent a significant contribution to the field.At the same time, and notwithstanding the above-mentioned criteria, it will serve as a platform for the presentation early reports and ideas that will stimulate research on brain aging. Registered Reports will be of interest to clinical scientists, but also to researchers undertaking experiments in animals.
Aims Aging and Health Research (AHR) is an international, peer-reviewed open access journal that publishes articles from a global research community. The aims of this journal is to establish an innovative forum of global aging and health research to advance knowledge in diverse disciplines, to promote early detection, diagnosis, treatment, and intervention of chronic diseases; to disseminate knowledge for optimal translation of research findings into policy and practical settings; to communicate new ideas, findings, perspectives, and research directions; to advocate public policies promoting aging and health in a global context.Scope Aging and Health Research (AHR) welcomes the submission of original and review articles, short communications and perspectives/commentaries. The topics of this journal are relevant to interdisciplinary investigations, integrative and translational articles, related to: diagnosis, treatment, etiology, risk factors, early detection, prognosis, clinical interventions, prevention, and new models of health services in aging related diseases and health status. An online-only journal, AHR is focused on pharmacology, nursing, epidemiology, public health, dentistry, behavior, neurology, psychiatry, gerontology, geriatrics, social work, global health, sociology, allied health, health services research, health economics, political science, and public policy.
Archives of Gerontology and Geriatrics Plus is a companion title to the well-established and respected journal Archives of Gerontology and Geriatrics. It is an open access, quarterly, international journal integrating Experimental, Clinical, and Social Studies on Ageing.Archives of Gerontology and Geriatrics Plus serves as a platform for publishing papers within the domains of aging biology, experimental gerontology, and clinical and social gerontology. The primary objective of the journal is to facilitate the exchange of advanced knowledge among experts in these specialized research fields. We welcome experimental papers that delve into the fundamental mechanisms of aging, spanning molecular, cellular, tissue, and organ levels.Our journal considers clinical papers for publication if they introduce novel insights or hold fundamental significance for the understanding of human aging and healthcare for the elderly. Purely descriptive clinical papers are eligible for acceptance only when their results offer room for further interpretation. Moreover, we eagerly invite papers addressing pharmacological interventions targeting age-related conditions in humans.Additionally, we extend an invitation for submissions focusing on the social dimensions of gerontology. Such papers are encouraged if they contribute to a broader understanding of aging epidemiology, as well as the efficacy and operational methodologies of social institutions dedicated to elderly healthcare.
Brain Disorders is a gold open access, online-only, multidisciplinary journal that publishes across a broad range of scientific and clinical disciplines, related to the diseases of the nervous system. The journal is a leading intellectual medium, promoting dialogue among basic and clinical scientists interested in topics from single molecules to behavior and from bench to the bedside.We are committed to publishing and widely disseminating high-quality articles that influence scientific thinking, understanding of disease mechanisms, and clinical practice.Brain Disorders welcomes the submission of original and review articles, meta-analysis, short communications, technical notes, clinical case reports, and perspectives/commentaries. We publish in all related basic science and clinical areas including but not limited to: cellular & molecular neuroscience, biochemistry, genetics & genomics, bioinformatics & computational neuroscience, neuropharmacology, neuroimmunology, neurotechnology, behavioural neuroscience, novel therapeutics, diagnostics and biomarkers, pediatric and adult neurology, neurosurgery, neuropathology, neuroimaging, neuro-oncology, neurophysiology, neuroendocrinology, and psychiatry.The criteria for publication in Brain Disorders are scientific originality, validity, significance, and rigor, as well as the level of interest to the journal's interdisciplinary readership. The submissions are assessed against these criteria through a rapid, rigorous, fair and efficient peer-review process. The editorial team is comprised of international experts in their respective fields. They adhere to the core principles and policies of the Committee on Publication Ethics (COPE, Committee on Publication Ethics) and the International Committee of Medical Journal Editors (ICMJE, International Committee of Medical Journal Editors) to ensure the integrity of the peer-review process.
Official Journal of The International Society of Vascular Behavioural and Cognitive DisordersCerebral Circulation - Cognition & Behavior (CCCB) is a peer-reviewed open access journal that publishes articles relevant to the progress and understanding of vascular dementia and Alzheimer disease. An online-only journal, CCCB considers original papers and review articles in clinical, experimental and basic science research. CCCB welcomes submissions in the fields of vascular cognitive disorders, vascular cognitive impairment, vascular dementia, vascular depression, cerebral blood flow, aging and cognition, cerebrovascular factors to degenerative dementia.In particular, CCCB is interested in:Population-based studies on vascular dementiaPublic Health aspects for planning and implementation of prevention programs in vascular dementia at population levelCorrelation studies dealing with cognitive effects of large-vessel strokesStudies on the effects of hypoperfusion due to heart disease or circulatory disturbancesAdvances in brain imaging in the pathogenesis of vascular dementiaAdvances in fluid biomarkers for diagnostic purposes and in the pathogenesis of vascular cognitive disordersBasic and clinical research on the role of sleep and glymphatic circulation in vascular and degenerative forms of dementia.Clinical studies on the multiple manifestations of vascular cognitive disordersStudies on executive function in vascular dementiaDevelopment of bedside tests and correlations with imaging methodsAnimal models of amyloid angiopathy and other models relevant to vascular dementiaControlled clinical trials of more effective treatments for vascular dementia and its neuropsychiatric complicationsStudies on traditional and newer risk factors and mechanisms of control, including hypertension, metabolism, lipids, endocrinology, dietetics, nutrition, diabetes, cardiology and cardiovascular surgeryBenefits to authors We provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Read more about our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, you can visit our Support Center.
Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.
The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-Chief, Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
Neurobiology of Aging publishes the results of studies in behavior, biochemistry, cell biology, endocrinology, molecular biology, morphology, neurology, neuropathology, pharmacology, physiology and protein chemistry in which the primary emphasis involves mechanisms of nervous system changes with age or diseases associated with age. Reviews and primary research articles are included, occasionally accompanied by open peer commentary. Letters to the Editor and brief communications are also acceptable. Brief reports of highly time-sensitive material are usually treated as rapid communications in which case editorial review is completed within six weeks and publication scheduled for the next available issue. The accepted abbreviation for Neurobiology of Aging for bibliographic citation is Neurobiol. AgingBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.comAuthors are also welcome to submit their manuscripts to the journal's open access companion title, Aging Brain.
The American Journal of Geriatric Psychiatry: Open Science, Education, and Practice (AJGP: OSEP) is an authoritative source of information for the rapidly expanding and multi-faceted field of geriatric mental health. It is an international, peer-reviewed, open-access journal that publishes research on clinical care, education, and investigation in different fields of geriatric mental health research, education, and practice. Geriatric MH research, education, and practice are all truly interdisciplinary at their best, and increasingly trans-disciplinary.Both The American Journal of Geriatric Psychiatry (AJGP) and AJGP: OSEP are the official journals of the American Association for Geriatric Psychiatry (AAGP), and both are published by Elsevier.Mission StatementThe mission of AJGP: OSEP is to improve health, health care, and health equity world-wide through open-access dissemination of high-quality, innovative, geriatric behavioral health science, education, practice, and commentary. Authors include a broad range of clinicians, educators, and researchers. In addition, AJGP: OSEP will publish research, educational initiatives and novel clinical practice models—all by a broad range of authors, whether they be academicians, patients, poets, payors, policy makers, social scientists, or scholars of philosophy relevant to aging. A balance of good science and of humanism will be at the core of the AJGP: OSEP mission.